Conclusions The combination of bevacizumab and erlotinib showed antitumor activity in patients with HLRCC-associated or sporadic papillary renal-cell carcinoma.

To the Editor: Linehan et al. (Jan. 14 issue)1 report on a comprehensive molecular characterization of papillary renal-cell carcinomas, and they describe three individual subgroups of type 2 papill ...

Clear cell papillary renal cell carcinoma is a type of kidney cancer. Healthcare professionals now refer to it as clear cell papillary renal cell tumor.

New findings shows that a non-clear cell form of kidney cancer known as papillary RCC, which accounts for 12 percent of all RCC, responds differently to sunitinib -- a standard frontline treatment ...

New findings shows that a non-clear cell form of kidney cancer known as papillary RCC, which accounts for 12 percent of all RCC, responds differently to sunitinib -- a standard frontline treatment ...

Papillary renal cell cancer (RCC) is associated with simple renal cysts (SRCs), new findings from a Finnish study suggest. Harri Visapää, MD, of Helsinki University Central Hospital and the ...

Do calcified deposits in renal papillae contribute to the development of papillary COM calculi?

Background: Papillary kidney cancer, which occurs in 15% of patients with kidney cancer, can be aggressive and there is currently no effective form of therapy for this disease. To evaluate the ...

Did you know that certain medications can cause symptom of 'Renal papillary necrosis'. Find these drugs listed on the page and be warned of similar symptoms as possible side-effects.

The researchers found that types 1 and 2 papillary renal-cell carcinomas were characterized by specific genetic alternations, with type 2 subclassified into three individual subtypes based on ...

COM papillary calculi were identified; a typical papillary COM stone (Figure 1) consists of an eccentric core located near the concave zone, where it attaches to the papillae, and a radially ...

It has emerged that of the 38,000 Americans diagnosed with renal cell carcinoma (RCC) each year, approximately 20 percent have non-clear cell forms of the disease.